Cortesi, Paolo Angelo
Fornari, Carla http://orcid.org/0000-0002-9609-9556
Gisondi, Paolo
Iannone, Florenzo
Antonazzo, Ippazio Cosimo
Aloisi, Elisabetta
Fiocchi, Martina
Ritrovato, Daniela
Mantovani, Lorenzo Giovanni
Funding for this research was provided by:
Novartis
Article History
Accepted: 27 February 2023
First Online: 16 March 2023
Declarations
:
: The study was supported by a grant from Novartis SpA. There are no grant numbers to declare. Novartis also provided support in the form of salaries for Elisabetta Aloisi, Martina Fiocchi and Daniela Ritrovato. The specific roles of these authors are articulated in the ‘author contributions’ section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Novartis SpA also provided the open access fee.
: Paolo Angelo Cortesi has received a research grant from Baxalta, now part of Shire, and speaking honoraria from Pfizer and Roche. Lorenzo Giovanni Mantovani has received grants and personal fees from Bayer AG, Boehringer Ingelheim, Pfizer and Daiichi-Sankyo. Carla Fornari and Ippazio Cosimo Antonazzo have no conflicts of interest to disclose. Paolo Gisondi has served as a speaker for Abbvie, Almirall, Eli Lilly, Novartis, Jannsen, Pfizer, UCB, Sanofi and Pierre Fabre. Fiorenzo Iannone received speaker’s fees and consultation grants from AbbVie, Actelion, BMS, Biogen, Lilly, MSD, Pfizer, Roche, Sanofi and UCB outside the submitted work. Elisabetta Aloisi, Martina Fiocchi and Daniela Ritrovato are employees of Novartis Pharma SpA Italy. This does not alter our adherence to Journal policies on sharing data and materials. The marketed product secukinumab is associated with this research.
: Ethical approval is not required for simulation-based studies in the present study’s jurisdiction.
: Not relevant to this study.
: Not relevant to this study.
: The budget impact model structure and the data sources analysed during the current study are available from the corresponding author on reasonable request. All data used to construct the model from both primary and secondary sources has also been presented within this manuscript.
: The budget impact model structure is available from the corresponding author on reasonable request.
: All authors contributed to conception and planning of the study. PAC and CF performed the analysis, which was reviewed by all the other authors. The first draft of the manuscript was written by PAC and CF and all authors commented on previous versions of the manuscript. All authors read and approved the final version of the manuscript.